03:41 AM EDT, 09/19/2025 (MT Newswires) -- Katherine Stueland, Director, Chief Executive Officer, on September 16, 2025, sold 10,501 shares in GeneDx Holdings ( WGS ) for $1,275,585. Following the Form 4 filing with the SEC, Stueland has control over a total of 14,578 Class A common shares of the company, with 14,578 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1818331/000168957525000003/xslF345X05/form4-09182025_100930.xml